<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20170551</PMID><DateCompleted><Year>2010</Year><Month>04</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2010</Year><Month>Feb</Month><Day>22</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>The cross-reactivity of the enterovirus 71 to human brain tissue and identification of the cross-reactivity related fragments.</ArticleTitle><Pagination><StartPage>47</StartPage><MedlinePgn>47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1743-422X-7-47</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">EV71 occasionally cause a series of severe neurological symptoms, including aseptic meningitis, encephalitis, and poliomyelitis-like paralysis. However, the neurological destruction mechanism was remained to be clarified. This study described the cross reaction between EV71 induced IgG and human brain tissue.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Cross reaction of the IgG from 30 EV71 infected patients' sera to human tissues of cerebra was observed, which suggested that some EV71 antigens could induce IgG cross-reactivity to human cerebra. To identify the regions of EV71 virus that containing above antigens, the polypeptide of virus was divided into 19 peptides by expression in prokaryotes cell. Mouse anti-sera of these peptides was prepared and applied in immunohistochemical staining with human adult and fetus brain tissue, respectively. The result indicated the 19 peptides can be classified into three groups: strong cross-reactivity, weak cross-reactivity and no cross-reactivity with human brain tissue according the cross reaction activity. Then, the increased Blood Brain Barrier (BBB) permeability and permits IgG entry in neonatal mice after EV71 infection was determined.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">EV71 induced IgG could enter BBB and cross-reacted with brain tissue in EV71 infected neonatal mice, and then the peptides of EV71 that could induce cross-reactivity with brain tissue were identified, which should be avoided in future vaccine designing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Chun Shi</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) &amp; Comparative Medicine Centre, Peking Union Medical Collage (PUMC), Chao Yang Strict, Pan Jia Yuan Nan Li No,5, Beijing 100021, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jiang Ning</ForeName><Initials>JN</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wan Bo</ForeName><Initials>WB</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Chun Mei</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shu Zhu</ForeName><Initials>SZ</Initials></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xue Zhong</ForeName><Initials>XZ</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiao Lin</ForeName><Initials>XL</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yan Feng</ForeName><Initials>YF</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lian Feng</ForeName><Initials>LF</Initials></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Chuan</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001923" MajorTopicYN="N">Brain Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>2</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20170551</ArticleId><ArticleId IdType="pmc">PMC2839975</ArticleId><ArticleId IdType="doi">10.1186/1743-422X-7-47</ArticleId><ArticleId IdType="pii">1743-422X-7-47</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195&#x2013;205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Oberste MS, Alexander JP Jr, Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999;73:9969&#x2013;9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortner B, Huang CW, Schmid D, Mutz I, Wewalka G, Allerberger F, Yang JY, Huemer HP. Epidemiology of enterovirus types causing neurological disease in Austria 1999-2007: detection of clusters of echovirus 30 and enterovirus 71 and analysis of prevalent genotypes. J Med Virol. 2009;81:317&#x2013;324. doi: 10.1002/jmv.21374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21374</ArticleId><ArticleId IdType="pubmed">19107980</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowlkes AL, Honarmand S, Glaser C, Yagi S, Schnurr D, Oberste MS, Anderson L, Pallansch MA, Khetsuriani N. Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis. 2008;198:1685&#x2013;1691. doi: 10.1086/592988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/592988</ArticleId><ArticleId IdType="pubmed">18959496</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrich S, Weinbrecht A, Schreier E. Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch Virol. 2009;154:1139&#x2013;1142. doi: 10.1007/s00705-009-0413-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-009-0413-x</ArticleId><ArticleId IdType="pubmed">19506798</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol. 2005;43:6171&#x2013;6175. doi: 10.1128/JCM.43.12.6171-6175.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.12.6171-6175.2005</ArticleId><ArticleId IdType="pmc">PMC1317214</ArticleId><ArticleId IdType="pubmed">16333123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gau SS, Chang LY, Huang LM, Fan TY, Wu YY, Lin TY. Attention-deficit/hyperactivity-related symptoms among children with enterovirus 71 infection of the central nervous system. Pediatrics. 2008;122:e452&#x2013;458. doi: 10.1542/peds.2007-3799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3799</ArticleId><ArticleId IdType="pubmed">18606624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Wang SW, Tung YY, Chen SH. Enterovirus 71 Infection of Human Dendritic Cells. Exp Biol Med (Maywood) 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">19596831</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu JP, Xu ZG, Chen H, Zhang X, Fan DY, Wang J. Primary detection of pathogen from children with hand, foot, and mouth disease in Beijing, 2007. Bing Du Xue Bao. 2009;25:23&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">19437882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding NZ, Wang XM, Sun SW, Song Q, Li SN, He CQ. Appearance of mosaic enterovirus 71 in the 2008 outbreak of China. Virus Res. 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">19540282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Chang KC, Kao CM, Chang SP, Tung YY, Chen SH. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J Virol. 2009;83:6477&#x2013;6483. doi: 10.1128/JVI.00434-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00434-09</ArticleId><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916&#x2013;7924. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15:794&#x2013;797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CS, Yao YC, Lin SC, Lee YP, Wang YF, Wang JR, Liu CC, Lei HY, Yu CK. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol. 2007;81:8996&#x2013;9003. doi: 10.1128/JVI.00236-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00236-07</ArticleId><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Yu CK, Wang YF, Liu CC, Su IJ, Lei HY. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol. 2004;85:69&#x2013;77. doi: 10.1099/vir.0.19423-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19423-0</ArticleId><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Iwasaki T, Ami Y, Tano Y, Harashima A, Suzaki Y, Sato Y, Hasegawa H, Sata T, Miyamura T, Shimizu H. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J Gen Virol. 2004;85:2981&#x2013;2989. doi: 10.1099/vir.0.79883-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79883-0</ArticleId><ArticleId IdType="pubmed">15448361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata N, Shimizu H, Ami Y, Tano Y, Harashima A, Suzaki Y, Sato Y, Miyamura T, Sata T, Iwasaki T. Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71. J Med Virol. 2002;67:207&#x2013;216. doi: 10.1002/jmv.2209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2209</ArticleId><ArticleId IdType="pubmed">11992581</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Nagata N, Iwata N, Ami Y, Suzaki Y, Mizuta K, Iwasaki T, Sata T, Wakita T, Shimizu H. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol. 2007;81:9386&#x2013;9395. doi: 10.1128/JVI.02856-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02856-06</ArticleId><ArticleId IdType="pmc">PMC1951441</ArticleId><ArticleId IdType="pubmed">17567701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Sun J, Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J Virol. 2008;82:7591&#x2013;7600. doi: 10.1128/JVI.00768-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00768-08</ArticleId><ArticleId IdType="pmc">PMC2493310</ArticleId><ArticleId IdType="pubmed">18508884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman GL, Kaye JA, Moore M, Waichunas D, Carlson NE, Quinn JF. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology. 2007;68:1809&#x2013;1814. doi: 10.1212/01.wnl.0000262031.18018.1a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000262031.18018.1a</ArticleId><ArticleId IdType="pmc">PMC2668699</ArticleId><ArticleId IdType="pubmed">17515542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganor Y, Goldberg-Stern H, Amrom D, Lerman-Sagie T, Teichberg VI, Pelled D, Futerman AH, Zeev BB, Freilinger M, Verheulpen D. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy. Clin Dev Immunol. 2004;11:241&#x2013;252. doi: 10.1080/17402520400001736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17402520400001736</ArticleId><ArticleId IdType="pmc">PMC2486323</ArticleId><ArticleId IdType="pubmed">15559370</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Yang F, Zhao R, Zhao L, Guo D, Jin Q. Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. J Virol Methods. 2009;159:233&#x2013;238. doi: 10.1016/j.jviromet.2009.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2009.04.002</ArticleId><ArticleId IdType="pubmed">19490979</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wang H, Du J, Zhao XS, Gong EC, Gao ZF, Zheng J. Molecular confirmation of enterovirus type 71 infection: a post-mortem study of two cases. Zhonghua Bing Li Xue Za Zhi. 2009;38:258&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">19575899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354:1682&#x2013;1686. doi: 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, Totsuka A, Nishio O. Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol. 2002;46:621&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">12437029</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Koh BK, Chan KP, Chua LT, James L, Goh KT. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore. 2009;38:106&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19271036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Hsia SH, Wu CT, Huang YC, Lin KL, Fang TY, Lin TY. Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002. Pediatr Infect Dis J. 2004;23:327&#x2013;332. doi: 10.1097/00006454-200404000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-200404000-00010</ArticleId><ArticleId IdType="pubmed">15071287</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lee CY, Kao CL, Fang TY, Lu CY, Lee PI, Huang LM. Hand, foot and mouth disease complicated with central nervous system involvement in Taiwan in 1980-1981. J Formos Med Assoc. 2007;106:173&#x2013;176. doi: 10.1016/S0929-6646(09)60236-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0929-6646(09)60236-9</ArticleId><ArticleId IdType="pubmed">17339164</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007;356:1226&#x2013;1234. doi: 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CY, Chang YC, Huang CC, Lui CC, Lee KW, Huang SC. Acute flaccid paralysis in infants and young children with enterovirus 71 infection: MR imaging findings and clinical correlates. AJNR Am J Neuroradiol. 2001;22:200&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975539</ArticleId><ArticleId IdType="pubmed">11158910</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC. Neurologic complications of enterovirus 71 infection in children: lessons from this Taiwan epidemic. Acta Paediatr Taiwan. 2001;42:5&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11270188</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyler KL. Emerging viral infections of the central nervous system: part 1. Arch Neurol. 2009;66:939&#x2013;948. doi: 10.1001/archneurol.2009.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2009.153</ArticleId><ArticleId IdType="pmc">PMC2873855</ArticleId><ArticleId IdType="pubmed">19667214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KT, Munisamy B, Ong KC, Kojima H, Noriyo N, Chua KB, Ong BB, Nagashima K. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol. 2008;67:162&#x2013;169. doi: 10.1097/nen.0b013e318163a990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e318163a990</ArticleId><ArticleId IdType="pubmed">18219253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu TC, Wang YF, Lee YP, Wang JR, Liu CC, Wang SM, Lei HY, Su IJ, Yu CK. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol. 2007;81:10310&#x2013;10315. doi: 10.1128/JVI.00372-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00372-07</ArticleId><ArticleId IdType="pmc">PMC2045469</ArticleId><ArticleId IdType="pubmed">17626076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine. 2008;26:1855&#x2013;1862.</Citation><ArticleIdList><ArticleId IdType="pubmed">18329759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou BP, Liu WL, Xie JJ, Chen XC, Xu LM, Tan Y, Liu YX, Yang GL. Expression of recombinant VP1 protein of enterovirus 71 and development of serological assay for detection of EV71 infection. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008;22:492&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">19544656</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HL, Huang JY, Chu TW, Tsai TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, Chen CM. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine. 2008;26:2882&#x2013;2889. doi: 10.1016/j.vaccine.2008.03.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2008.03.041</ArticleId><ArticleId IdType="pubmed">18450335</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Ang RX, Alonso S, Chow VT, Quak SH, Poh CL. Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in Western blots. Clin Microbiol Infect. 2008;14:286&#x2013;288. doi: 10.1111/j.1469-0691.2007.01904.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2007.01904.x</ArticleId><ArticleId IdType="pubmed">18076666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivasamugham LA, Cardosa MJ, Tan WS, Yusoff K. Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits. J Med Virol. 2006;78:1096&#x2013;1104. doi: 10.1002/jmv.20668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20668</ArticleId><ArticleId IdType="pubmed">16789020</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CH, Chu C, He CC, Lin TY. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect. 2006;8:1671&#x2013;1678. doi: 10.1016/j.micinf.2006.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2006.01.021</ArticleId><ArticleId IdType="pubmed">16815726</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HF, Chang MH, Chiang BL, Jeng ST. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine. 2006;24:2944&#x2013;2951. doi: 10.1016/j.vaccine.2005.12.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2005.12.047</ArticleId><ArticleId IdType="pubmed">16448730</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen AL, Morrey JD, Smee DF, Sidwell RW. Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice. Antiviral Res. 2007;75:104&#x2013;112. doi: 10.1016/j.antiviral.2006.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2006.11.013</ArticleId><ArticleId IdType="pmc">PMC2040264</ArticleId><ArticleId IdType="pubmed">17223204</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoni G, Navone R, Lunardi C, Tridente G, Bason C, Sivori S, Beri R, Dolcino M, Valletta E, Corrocher R, Puccetti A. In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes. PLoS Med. 2006;3:e358. doi: 10.1371/journal.pmed.0030358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0030358</ArticleId><ArticleId IdType="pmc">PMC1569884</ArticleId><ArticleId IdType="pubmed">16984219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78:381&#x2013;385. doi: 10.1136/jnnp.2006.100644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.100644</ArticleId><ArticleId IdType="pmc">PMC2077770</ArticleId><ArticleId IdType="pubmed">16980333</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigoriadis N, Hadjigeorgiou GM. Virus-mediated autoimmunity in Multiple Sclerosis. J Autoimmune Dis. 2006;3:1. doi: 10.1186/1740-2557-3-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1740-2557-3-1</ArticleId><ArticleId IdType="pmc">PMC1397830</ArticleId><ArticleId IdType="pubmed">16504001</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloka S. Observations on recent studies showing increased co-occurrence of autoimmune diseases. J Autoimmun. 2002;18:251&#x2013;257. doi: 10.1006/jaut.2002.0588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.2002.0588</ArticleId><ArticleId IdType="pubmed">12126638</ArticleId></ArticleIdList></Reference><Reference><Citation>Seissler J, de Sonnaville JJ, Morgenthaler NG, Steinbrenner H, Glawe D, Khoo-Morgenthaler UY, Lan MS, Notkins AL, Heine RJ, Scherbaum WA. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease. Diabetologia. 1998;41:891&#x2013;897. doi: 10.1007/s001250051004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001250051004</ArticleId><ArticleId IdType="pubmed">9726590</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, Wu CN, Shih SR, Ho MS. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine. 2002;20:2485&#x2013;2493. doi: 10.1016/S0264-410X(02)00182-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(02)00182-2</ArticleId><ArticleId IdType="pubmed">12057603</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin JY, Shih SR, Pan M, Li C, Lue CF, Stollar V, Li ML. hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol. 2009;83:6106&#x2013;6114. doi: 10.1128/JVI.02476-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02476-08</ArticleId><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>He YQ, Yang H, Li LL, Tan J, Zhou L, Mao LS, Yang F, Liu JJ, Lv X. Genotype analysis of enterovirus type 71 detected from patients with hand-foot-mouth disease in Shenzhen. Zhonghua Liu Xing Bing Xue Za Zhi. 2008;29:790&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">19103116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248&#x2013;254. doi: 10.1016/0003-2697(76)90527-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(76)90527-3</ArticleId><ArticleId IdType="pubmed">942051</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Ami Y, Wakita T, Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J Virol. 2008;82:1787&#x2013;1797. doi: 10.1128/JVI.01798-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito W, Kurosawa Y. Development of an artificial antibody system with multiple valency using an Fv fragment fused to a fragment of protein A. J Biol Chem. 1993;268:20668&#x2013;20675.</Citation><ArticleIdList><ArticleId IdType="pubmed">8376416</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>